rss0343
Small moleculeexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Apr 7, 2024 (NCT07101965)
Timeline
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07289464 | Phase 1 | Dec 31, 2025 | Reistone Biopharma Company Limited |
| NCT06775340 | Phase 2 | Jan 22, 2025 | Hengrui Therapeutics, Inc. |
| NCT07101965 | Phase 1 | Apr 7, 2024 | Hengrui Therapeutics, Inc. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Hengrui Therapeutics, Inc. | For profit | 2 | 2 | 2 | 2024 |
| Reistone Biopharma Company Limited | For profit | 1 | 1 | 1 | 2025 |
2 organizations
Page 1 / 1